Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.69 - $5.81 $669,625 - $2.3 Million
-396,228 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$4.09 - $8.67 $492,374 - $1.04 Million
-120,385 Reduced 23.3%
396,228 $2.1 Million
Q3 2021

Nov 15, 2021

BUY
$6.6 - $12.78 $1.96 Million - $3.8 Million
297,284 Added 135.54%
516,613 $4.25 Million
Q2 2021

Aug 16, 2021

BUY
$12.14 - $20.35 $1.25 Million - $2.1 Million
103,232 Added 88.92%
219,329 $2.9 Million
Q1 2021

May 17, 2021

BUY
$16.87 - $31.21 $1.96 Million - $3.62 Million
116,097 New
116,097 $2.36 Million

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Parian Global Management LP Portfolio

Follow Parian Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Parian Global Management LP with notifications on news.